PharmaShots | Incisive News in 3 Shots

Subscribe Now

Boundless Bio

Boundless Bio Doses First Patient with BBI-825 in the P-I/II Study for Cancer Treatment

Boundless Bio Doses First Patient with BBI-825 in the P-I/II Study for Cancer Treatment

April 12, 2024

Boundless Bio Entered into a Clinical Trial Collaboration and Supply Agreement with Taiho Oncology to Evaluate Lytgobi + BBI-355 for FGFR Amplified Solid Tumors

Boundless Bio Entered into a Clinical Trial Collaboration and Supply Agreement with Taiho Oncology to Evaluate Lytgobi + BBI-355 f...

September 19, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us